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ABSTRACT
Background: Histiocytic sarcoma can present in a localized or disseminated form, being a malignant neoplasm derived 
from interstitial dendritic cells. Another form of the disease is called hemophagocytic histiocystic sarcoma (HHS), which 
originates from macrophages located in the splenic red pulp and bone marrow. HHS is a rare neoplasm with unknown 
etiology and rapid development. It mainly affects middle-aged to elderly animals. It primarily affects the spleen and bone 
marrow, with occurence of metastases in other organs. Some canine breeds are considered more predisposed to this neo-
plasia, among them the Rottweiler. The aim of this study was to report a case of HHS in a Rottweiler dog.
Case: An 8-year-old Rottweiler suffering from hyporexia and progressive weight loss for a month was attended at the 
Veterinary Hospital of State University of Maringá. On physical examination, he only presented mild discomfort on 
abdominal palpation. Blood count was performed, which revealed mild thrombocytopenia (145,000/µL, reference value 
for the species 150,000-500,000/µL). The Polymerase Chain Reaction (PCR) exam was requested for babesiosis and eh-
rlichiosis, due to a history of ectoparasites. The animal was released with the prescription of Doxycycline at a dose of 10 
mg/kg orally for 28 days. After 5 days, the condition worsened and the animal returned with emesis, apathy and hyporexia, 
being hospitalized. Abdominal ultrasound, blood count, urinalysis, serum urea and creatinine tests were requested. Among 
the hematological changes, thrombocytopenia (116,000/µL) and the appearing of regenerative anemia and atypical round 
cells with ample and slightly basophilic cytoplasm in the smear, similar to histiocytes, stood out. On ultrasound examina-
tion, splenomegaly was observed with hypoechogenic areas. Ultrasound-guided fine-needle aspiration cytology (FNAC) 
of the spleen was performed, which revealed the presence of abundant cellularity consisting of round cells arranged 
individually and in small groups, with variable nucleus / cytoplasm ratio, slightly basophilic cytoplasm and, sometimes, 
vacuolized. Eccentric nucleus with chromatin ranging from loose to dense, with evident and often multiple nucleus. In 
addition, a large number of multinucleated giant cells, mitosis figures (sometimes atypical) and intense anisocytosis and 
anisocariosis were observed. Furthermore, it was possible to observe erythrophagocytic activity, alterations compatible 
with histiocytic sarcoma (HS). After 10 days of the first visit, the animal died. At necropsy, samples from altered areas of 
the spleen, lungs and lymph nodes were collected and sent for histopathological and immunohistochemical examination, 
in which the diagnosis of hemophagic histiocytic sarcoma was confirmed, in addition to lungs and lymph node metastasis.
Discussion: The prognosis of HHS is the worst among histiocytic disorders, as it is associated with coagulopathies and 
severe anemia due to erythrophagocytic activity, as occurred in the case presented, with a maximum survival time between 
one to two months. The described animal died ten days after showing the first clinical signs. The immunohistochemistry 
technique using HLA-DR, CD18, CD163, and CD11d markers was essential to confirm the cell line. Positivity for CD11d 
marker was found, which allowed to classify the neoplasm as hemophagocytic HS. This report exposes the importance of 
cytological examination for screening and histopathological and immunohistochemical tests to confirm the diagnosis of 
this extremely aggressive neoplasm.
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INTRODUCTION
Hemophagic or hemophagocytic histiocytic 
sarcoma (HHS) is currently the only histiocytic di-
sorder described in dogs and cats that originates from 
macrophages located in the splenic red pulp and bone 
marrow [9,10]. Unlike dendritic cells neoplasms, 
the hemophagocytic form does not develop distinct 
masses, but results in diffuse hepatomegaly and sple-
nomegaly [5].
Histiocytic sarcomas are uncommon in domes-
tic dog population, however there is a high incidence 
in breeds such as Bernese Mountain Dog, Flat-coated 
Retriever, Golden Retriever, Rottweiler and Labrador 
Retriever, which suggests hereditary risk factors [7,10]. 
Cytogenetic analysis demonstrated the loss of several 
tumor suppressor genes in cases of canine histiocytic 
sarcoma [3,7].
 The hemophagocytic type of histiocytic sarcoma 
is a rare neoplasm, of unknown etiology and rapid deve-
lopment. It initially affects the spleen and bone marrow, 
forming metastases in other organs such as liver and 
lungs. The histiocytic sarcoma complex affects mainly 
middle-aged to elderly animals, although there are reports 
in young animals and there is no sexual predisposition 
[1,3-5,11]. This paper aims to report a rare case of his-
tiocytic hemophagocytic sarcoma in a Rottweiler dog.
CASE
An 8-year-old male Rottweiler, weighing 
46.2 kg, arrived at the Veterinary Hospital of the 
State University of Maringá - Umuarama Campus, 
presenting hypoxia and progressive weight loss for a 
month. On physical examination, he only presented 
mild discomfort on abdominal palpation. A blood count 
was requested, which showed mild thrombocytopenia 
(145,000/µL).
After this result, the Polymerase Chain Re-
action (PCR) exam was requested to investigate 
babesiosis and ehrlichiosis, since the occurrence of 
hemoparasitosis is common in the region and there 
was a history of ectoparasites. The animal was released 
and Doxycycline1 was prescribed at a dose of 10 mg/
kg orally for 28 days, as a therapeutic diagnosis while 
the PCR result was not available.
After 5 days, the animal returned with clinical 
worsening, presenting emesis, apathy and hyporexia, and 
was hospitalized. Abdominal ultrasound, blood count, 
urinalysis, serum urea and creatinine tests were requested.
In the second blood count (Table 1), red blood 
cells with mild anisocytosis and polychromasia, 
neutrophilic leukocytosis with regenerative left shift, 
worsening thrombocytopenia and a population of round 
cells not classified in the tail of the blood smear, whi-
ch were characterized by being round with abundant 
cytoplasm, and slightly basophilic, eccentric round to 
oval nucleus with finely punctiform chromatin, similar 
to histiocytes were found.
The serum urea (65 mg/dL) and creatinine (1.8 
mg/dL) values were above the reference values for the 
species (reference: 21.4-59.92 mg/dL and 0.5-1.5 mg/
dL, respectively) and urinalysis revealed high density 
(> 1.040), proteinuria (100 mg/dL) and moderate pre-
sence of hyaline and granular cylinders. The ultrasound 
examination revealed splenomegaly and the presence 
of two hypoechogenic rounded structures in the splenic 
parenchyma, one measuring 0.71 cm x 0.52 cm and the 
other 0.77 cm x 0.6 cm. Due to the presence of these 
structures in the spleen, ultrasound-guided fine-needle 
aspiration cytology (FNAC) was performed.
 Cytology revealed the existence of an abun-
dant cellularity consisting of round cells arranged in-
dividually and in small groups, with a variable nucleus 
/ cytoplasm ratio, slightly basophilic cytoplasm and 
sometimes vacuolated. Eccentric nucleus with chro-
matin ranging from loose to dense, with evident and 
often multiple nucleus. In addition, a large number of 
multinucleated giant cells, mitosis figures (sometimes 
atypical) and intense anisocytosis and anisocariosis 
were observed (Figure 1). Furthermore, it was possible 
to observe erythrophagocytic activity (Figure 2). Such 
characteristics are suggestive of histiocytic sarcoma, 
requiring histopathology for confirmation and immu-
nophenotyping to characterize the neoplasm.
In view of the FNAC result, the owner opted to 
perform palliative treatment at home, with omeprazole2, 
ranitidine2 and dipyrone2. After 2 days, the condition 
worsened and the animal returned with musculoskeletal 
weakness, anorexia, apathy, tachypnea, oligodipsia and 
hematuria. In a new blood test, there was worsening of 
thrombocytopenia and anemia, with moderate hypo-
chromia, mild anisocytosis and polychromia of the red 
blood cells, in addition to an increase in neutrophilic 
leukocytosis with left shift (Table 1) and an increase 
in atypical round cells in the blood smear. During this 
period, the PCR results came out, which was negative 
for Erlichia sp. and Babesia sp.
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Figure 6. Photomicrograph of the spleen with CD11d positive cytoplasmic 
markings that identifies the macrophages origin [Obj.40x].
Figure 1. The predominant population consists of round pleomorphic cells 
that were often multinucleated. Expressive anisocariosis and anisocytosis 
[Fast panotic; Obj.100x].
Figure 2. Fine-needle aspiration of the splenic nodule. Neoplastic cells 
showing erythrophagocytosis (arrows) [Fast panotic; Obj.100x].
Figure 3. Histological section of the spleen showing diffuse neoplastic 
cells in the organ. Giant, multinucleated cells with moderate anisocytosis 
and anisocariosis are observed [HE; Obj.40x].
Figure 4. Histological section of the lymph node showing scattered neo-
plastic cells in the lymphoid tissue [HE; Obj.40x].
Figure 5. Lung fragment showing an intense amount of neoplastic cells 
in the parenchyma and invading the blood vessel (arrow) [HE; Obj.40x].
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The animal worsened and died three days 
after hospitalization. At necropsy, splenomegaly with 
diffuse pallor was observed, as well as pale areas in 
the lung and mesenteric and mediastinal lymph nodes. 
Samples of these organs were collected for histopatho-
logical evaluation.
The morphological diagnosis of the histopa-
thological examination of the fragment of the spleen 
(Figure 3) confirmed the FNAC suggestive diagnosis 
and the fragments of lymph nodes (Figure 4) and lung 
(Figure 5) confirmed histiocytic sarcoma metastasis.
To discover the cell line and make the definitive 
diagnosis, an immunohistochemistry exam was reques-
ted, using the marker panel for histiocytic neoplasms: 
Figure 7. Photomicrograph of the lung showing positive cells with CD11d 
citoplasmic markings [Obj.40x].
Table 1. Second and Last blood count results from an 8-year-old Rottweiler with hemophagocytic histiocystic sarcoma.
Analyte Second blood Last blood Unity Reference
Red Blood Cells 5.06 3.89 x106/µL 5.5 - 8.5
Hemoglobin 12.5 8.6 g/dL 12 - 18
Hematocrit 33.5 26 % 37 - 55
MCV 66.1 66.8 fL 60 - 77
MCHC 36 33.1 g/dL 32 - 36
Metarubricytes 1 2 % 0
TPP 5.6 5.0 g/dL 6.0 - 8.0
Total Leukocytes 21,186 24,402 /µL 6,000 - 17,000
Bands 1,271 1,464 /µL 0 - 300
Neutrophils 17,161 20,742 /µL 3,000 - 11,500
Lymphocytes 1,059 1,220 /µL 1,000 - 4,800
Monocytes 1,271 732 /µL 150 - 1,350
Eosinophils 424 244 /µL 100 - 1,250
Platelets 116,000 78,000 /µL 150,000 - 500,000
MCV= Mean Corpuscular Volume; CHCM= Mean Corpuscular Hemoglobin Concentration; TPP= Total Plasma Protein.
Table 2. Results of the histiocytic neoplasms marker panel from an 8-year-old Rottweiler with hemophagocytic histiocystic sarcoma.
Antibodies Clone Results
CD11d Hemophagocytic Histiocytic Sarcoma 
Marker
CA12.10C12 Positive in neoplastic cells (Spleen, 
lung and lymph node)
HLA-DR Main Histocompatibility Complex 
MHC II
TAL.1B5 Positive in neoplastic cells (Spleen)
CD18 Histiocytic neoplasms Marker CA16.3C10 Positive in neoplastic cells (Spleen)
CD163 Histiocytic neoplasms and leukemias 
Marker
Polyclonal Positive in neoplastic cells (Spleen)
CD3 Epsilon chain T lymphocyte Receptor Polyclonal Negative in neoplastic cells (Spleen)
CD20 B Lymphoid lineage Marker Polyclonal Negative in neoplastic cells (Spleen)
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HLA-DR3, CD183, CD1633, CD33, CD203 and CD11d3, 
being the later specific for macrophages residing in 
hematopoietic sites, such as splenic red pulp and bone 
marrow (Figure 4). The result confirmed the diagnosis 
of histiocytic sarcoma of hemophagocytic type.
DISCUSSION
HHS is a rare neoplasm, of unknown etiology 
and rapid development. Its prognosis is the worst 
among histiocytic disorders, as it is associated with 
coagulopathies and severe anemia due to erythropha-
gocytic activity, with a maximum survival time betwe-
en one to two months [4]. In contrast, in a study by 
Moore et al. [10] with 17 dogs with HHS, the survival 
time ranged from two to 32 weeks. In this report, the 
patient died 10 days after the suggestive diagnosis of 
the cytopathological examination. In cases of HHS, 
the animal is often euthanized at the time of diagnosis 
due to the poor health conditions he is presented and 
the poor prognosis [6].
Several characteristics stated in this case corro-
borate the literature, where the rottweiler is reported as 
one of the most predisposed breeds to this neoplasm, 
in addition to preferentially affecting middle-aged to 
elderly animals [2-4,10]. Furthermore, in Rottweilers, 
Liao et al. [8] detected a high frequency of mutation in 
the MET proto-oncogene (coding for tyrosine kinase), 
which may contribute to the breed’s predisposition to 
neoplasms, including histiocytic sarcoma.
Animals with HHS show nonspecific clinical 
signs, such as lethargy, weight loss and pale mucous 
membranes, the same signs reported in the present case. 
The occurrence of splenomegaly with the presence of 
hypoechogenic rounded structures in the presented 
case differs from the literature, where splenomegaly is 
generally reported with no visible nodules in the sple-
nic parenchyma or in metastatic sites such as lung and 
liver, sometimes hepatomegaly is observed [2,4,10]. 
Thus, after the FNAC result, the presence of nodules 
in the spleen suggested the primary impairment of 
this organ.
The hematological changes of the evaluated 
dog showed an evolution consistent with the literatu-
re, where the development and worsening of anemia, 
thrombocytopenia and hypoproteinemia were obser-
ved. In addition, there are also reports of prolongation 
of thromboplastin partial time, hypoalbuminemia, 
hypocholesterolemia and hyperbilirubinemia [2,4,10]. 
Albumin was not measured, however, the hypoprotei-
nemia observed suggests that it is due to hypoalbumi-
nemia. Regenerative anemia, thrombocytopenia and 
hypoproteinemia agree with the results presented by 
Moore et al. [10], where 94%, 88% and 82% of dogs 
showed these changes, respectively. Many studies have 
demonstrated the presence of anemia in patients with 
histiocytic tumors, both related to erythrophagocytosis 
by neoplastic cells, and due to hypoplasia and infiltra-
tion of neoplastic histiocytes in the bone marrow [5].
 Serum urea and creatinine presented slightly 
above the reference values for the species, added to 
the high urinary density, indicate a pre-renal azotemia, 
due to dehydration caused by emesis and oligodipsia. 
However, the moderate presence of cylinders and pro-
teinuria indicate a probable acute kidney injury, and 
that the persistence of azotemia led to renal azotemia.
In FNAC, the erythrophagocytic activity ob-
served was decisive for suggesting the diagnosis. Even 
in cases where histiocytes are well differentiated, the 
disease›s behavior is aggressive, with a high degree of 
metastasis in the liver, lung and lymph nodes, the latter 
occurring less frequently, in addition to the appearance 
of neoplastic cells in the blood smear [9].
At necropsy, macroscopic changes were ob-
served in the spleen, lung and lymph nodes, where 
samples were collected and sent for histopathological 
examination, confirming the cytological examination 
results and detecting lung and lymph node metastasis. 
The lesions observed in the spleen and lung agree with 
those presented by Moore et al. [10]. These authors 
also observed neoplastic infiltration in the liver, bone 
marrow and lymph nodes of five of the eleven dogs 
affected. In the present case, it was not possible to 
perform bone marrow collection. 
The diagnosis is based on the morphology 
of the tumor cells through cytology and histology, 
however the definitive diagnosis is obtained throu-
gh immunophenotyping by searching for the CD1a, 
CD11c / CD18 markers (originated in dendritic cells) 
or CD11d / CD18 markers (originated in macrophages) 
[2]. CD11d being expressed exclusively by macro-
phages present in splenic red pulp and bone marrow. 
Immunohistochemistry for CD18 markers is diffusely 
positive in all histiocytic tumors [3].
The immunohistochemistry technique allowed 
the establishment of the histiocytic origin (Table 2).
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The CD11d antibody, a specific marker for ma-
crophages, was positive and predominant in neoplastic 
cells from samples sent from the spleen, lung and lymph 
node. The other antibodies were made only in the spleen 
sample, the HLA-DR marker of the main histocompati-
bility complex MHC II, the CD18 marker of histiocytic 
neoplasms and the CD163 marker of histiocytic neoplas-
ms and leukemias were positive in the organ’s neoplastic 
cells, but with less prevalence in macrophages, since its 
main function is phagocytosis and not the presentation 
of antigens as in histiocytic disorders of dendritic cells. 
The CD20 antibody of lymphoid lineage B and the CD3 
receptor of epsilon T lymphocytes (both polyclonal) 
were also performed, being negative in the neoplastic 
cells of the spleen. Immunohistochemistry is essential 
to differentiate it from other round cell tumors, such as 
lymphomas, poorly differentiated mastocytomas and 
other histiocytic disorders, as a lymphocytic inflamma-
tory infiltrate can be observed [6].
It can be concluded that HHS is a neoplasm 
with nonspecific clinical signs, rapid development 
and poor prognosis, and complementary exams are 
extremely important for the diagnostic conclusion. 
Thus, in the present case, the cytological examination 
was a screening method and the histopathology and 
immunohistochemistry tests were essential to obtain 
the definitive diagnosis, with the CD11d marker being 
specific for the diagnostic confirmation of HHS.
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